Cardiac ablation and mapping
Clinical evidence
Explore clinical studies and evidence that evaluate our novel cardiac ablation technologies.
SPHERE Per-AF was a randomized trial of persistent AF patients comparing the Sphere-9™ catheter with the Affera™ mapping and ablation system to the Thermocool STSF™* SMARTTOUCH®* SF catheter with the CARTO®* 3 system.
PULSED AF evaluated the safety and effectiveness of the PulseSelect™ pulsed field ablation (PFA) system for the treatment of patients with paroxysmal (PAF) or persistent (PsAF) atrial fibrillation.
View data from the clinical trial assessing initial rhythm control of paroxysmal AF with cryoballoon ablation versus antiarrhythmic drugs.
View information on this clinical trial assessing the safety and efficacy of the Medtronic cryoballoon in treating persistent AF patients.
This trial assessed the use of the Freezor™ Xtra cardiac cryoablation catheter in treating AVNRT.
Learn more about this randomized study on the effectiveness of the Arctic Front™ and Arctic Front Advance™ cardiac cryoablation catheters.
Discover information on this 1:1 randomized, noninferiority study comparing cryoballoon and radiofrequency ablation.
®* and TM* Third-party brands are trademarks of their respective owners.
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.